In a prospective study, the etiology of community-acquired pneumonia (CAP) was investigated among consecutive patients admitted to an academic, urban public hospital in Seattle. The study population was uniquely young, was predominantly male, and had high rates of homelessness, cigarette smoking, alcoholism, injection drug use, and human immunodeficiency virus (HIV) infection. Leading causes of CAP among HIV-negative patients were aspiration, followed by Streptococcus pneumoniae, Legionella species, and Mycoplasma pneumoniae. Among HIV-positive patients, Pneumocystis carinii, Mycobacterium tuberculosis, S. pneumoniae, and M. pneumoniae were the most common etiologic agents. Severe CAP was associated with typical bacterial infections and aspiration pneumonia but not Legionella infection among HIV-negative patients and with Pseudomonas aeruginosa infections among HIVpositive patients. These findings emphasize the need to tailor empirical antibiotic therapy according to local patient populations and individual risk factors and highlight the importance of recognizing underlying HIV infection in patients who are hospitalized with CAP.
of CAP on the basis of presenting clinical and radiographic features [6] . Thus, initial antibiotic selection usually must be empirical and is based on the results of numerous studies of CAP etiology conducted mostly in western Europe and eastern North America [7, 8] . Surprisingly, no comprehensive CAP etiology data from patients who required hospitalization have been reported from many global regions, including all of western North America.
In general, the published guidelines for the management of CAP advocate empirical antibiotic selection on the basis of the age of the patient, the presence or absence of comorbid diseases, and, particularly in hospitalized patients, the initial severity of illness [9] [10] [11] [12] . Although these factors may influence the likelihood of individual causes of CAP, their utility in guiding empirical antibiotic choices for CAP are unknown, and patient outcomes appear to be similar whether or not these guidelines for antibiotic selection are followed [13] .
Finally, immunocompromised patients, especially those with human immunodeficiency virus (HIV) infection, have become recognized as a uniquely important population because of their increased risk for CAP and expanded spectrum of potential causes of CAP. Clinical information comparing HIV-negative and HIV-positive patients with CAP is quite limited, and all the published CAP management guidelines have excluded HIVpositive patients from consideration.
In this context, we studied 522 consecutive patients, including those with all stages of HIV infection, who required hospitalization for CAP over a 2-year period at an academic, urban public hospital in Seattle. Our major goal was to define the etiology of CAP at our institution, to determine whether there are unique features of local CAP epidemiology, to help guide empirical antibiotic therapy locally and at other institutions with similar patient populations, and to contribute important information about the etiology of CAP in HIV-positive persons.
Patients and Methods
Setting. Harborview Medical Center (HMC) is a 351-bed urban municipal-county hospital in Seattle (King County). Harborview is a full affiliate and major teaching hospital of the University of Washington School of Medicine. It is the primary mission of HMC to provide care for indigent, institutionalized, immigrant, and medically underserved patients in the county.
Identification of study patients. All patients admitted between 1 June 1994 and 30 May 1996 were prospectively screened for possible cases of CAP by checking the hospital admissions log daily for adult patients with diagnoses of pneumonia, asthma, congestive heart failure, sepsis, hypoxia, fever, tuberculosis, or empyema. These cases were reviewed for study eligibility according to an accepted CAP case definition [14, 15] : a new infiltrate on a chest radiograph made within 24 h of admission plus confirmatory clinical features, including either у1 major criterion (cough, sputum production, fever [temperature 137.9ЊC], or hypothermia [temperature !35.0ЊC]) or у2 minor criteria (pleuritic chest pain, dyspnea, altered mental status, abnormal chest examination findings, leukocytosis [white blood cell count 112,000 cells/mL], or left shift [110% band forms]). Patients were excluded if they were !18 years old, were transferred from another hospital, were hospitalized within 7 days before the index admission, were admitted for terminal care, or refused to give consent.
Clinical and diagnostic evaluation. A chest radiograph was required for entry into the study. Routine clinical tests included a complete blood count, serum chemistry tests, urinalysis, expectorated sputum Gram's stain and culture, and blood cultures. Sputum collection was not routinely supervised, but only specimens that passed the cytologic screening criteria of Murray and Washington [16] were accepted for further processing. Additional clinical diagnostic tests were done at the discretion of the treating physicians. Eligible patients were seen by a study investigator (usually within 24 h after admission) who obtained consent, recorded clinical information, and collected an acute serum specimen and a nasopharyngeal swab for respiratory virus culture. Convalescent serum samples were collected either at a subsequent outpatient clinic appointment or by special arrangement. Serum samples were stored frozen and were analyzed in paired fashion at the completion of the study. Anti-Legionella IgG, anti-Chlamydia pneumoniae IgG and IgM, and anti-Mycoplasma pneumoniae IgG and IgM antibody titers were measured by standard microimmunofluorescence methods, and nasopharyngeal swabs were cultured for respiratory viruses (influenza A and B viruses, parainfluenza viruses types 1-3, adenovirus, respiratory syncytial virus, and rhinovirus) by standard methods.
Assignment of etiology. The etiologic cause of pneumonia was defined by criteria adapted from those of Fang et al. [14] : a definitive diagnosis was assigned when a CAP pathogen was cultured from a normally sterile site, when a noncommensal organism (e.g., Mycobacterium tuberculosis, Legionella species, respiratory viruses, M. pneumoniae, C. pneumoniae, endemic fungi, or Pneumocystis carinii) was identified from any site, and when paired serologic testing revealed a у4-fold increase in titer of antibody to Legionella species, M. pneumoniae, or C. pneumoniae. A presumptive diagnosis was assigned when growth of a bacterial pathogen in sputum cultures was accompanied by a Gram's stain demonstrating a compatible organism predominant and was present in quantities у5 organisms/oil immersion field, when a single high serum antibody titer was observed (у1:1024 for Legionella species or C. pneumoniae IgG, у1:64 for M. pneumoniae IgG, or у1:16 for C. pneumoniae or M. pneumoniae IgM), when atypical mycobacteria were isolated from a single bronchoalveolar lavage (BAL) or induced sputum specimen, or when cytomegalovirus (CMV) was isolated from a BAL specimen. A presumptive diagnosis of aspiration pneumonia was assigned when no specific cause was identified as described above and when aspiration was witnessed or was suspected by the admitting clinicians. The cause of pneumonia was deemed to be unknown when no specific microbial cause or aspiration diagnosis was assigned according to the above criteria.
Data collection, definitions, and analysis. Demographic information, habits, underlying diseases, and prior medication histories were obtained from the patients and from their admission medical records. Diagnoses of alcoholism and other prior medical problems were made by patient reports or clinician chart notations. Chronic renal failure was defined as a patient's requiring hemodialysis or peritoneal dialysis for у1 month before admission. Chronic liver disease was defined as a history of cirrhosis, ascites, portal hypertension, or variceal bleeding. All study data were collected on a standardized data form, were double-entered into a computerized relational database (Access; Microsoft), and were verified for accuracy. Statistical analyses were completed by use of a statistical software package (SPSS). For comparisons between groups, the x 2 or Fisher's exact test was used for categorical variables, and Student's t test was used for continuous variables. Continuous variables that were not normally distributed were compared by use of the Mann-Whitney U test. The small fraction of patients enrolled more than once (5%) were treated as independent, with little expected impact on the analyses. A 2-tailed was considered P ! .05 to be significant.
Results
Study patients. We screened 1012 patients; 275 did not meet our inclusion criteria (261 had no new infiltrate, and 14 lacked clinical criteria for CAP), 74 were excluded (6 were too young, 63 had been recently hospitalized, and 5 were admitted for terminal care), and 47 declined to give consent. An additional 94 patients were discharged before they could be evaluated (none had a discharge diagnosis code that indicated pneumonia). Of the 663 patients who met our entry criteria, 522 (79%) were enrolled. The clinicians' admitting diagnosis was pneumonia in 492 cases (94%). The 30 cases given a different admitting diagnosis (usually bronchitis or chronic obstructive pulmonary disease [COPD] exacerbation) were reviewed by 2 of the investigators, and all were thought to be compatible with CAP because of their clinical and radiographic presentations, microbiologic results, and a favorable response to therapy that included an antibiotic.
Immune status. The 112 HIV-positive patients made up 21% of the study population. Ninety-seven of these patients were known to be HIV-positive when admitted. Fifteen of the 149 patients tested during the index admission were found to be HIV-positive. The HIV status of the remaining 276 patients was not established by clinical testing. Because Washington State law prohibits HIV testing without specific written informed consent, we were unable to determine the HIV status of each of these patients individually. However, only 5 (3%) of the 147 in this group who had serum available at the completion of the study were found to be HIV-positive by batched anonymous testing. Therefore, all patients with unknown HIV status were considered to be HIV-negative in the subsequent analyses.
One hundred four HIV-positive patients (93%) had CD4 lymphocyte counts determined at a median of 128 days before the index admission (76% within the previous year). Nearly all those tested had CD4 cell counts !500 cells/mL (92%), 67% had counts !200 cells/mL, and 46% had counts !50 cells/mL. Only 7 HIV-positive patients (6%) had CD4 cell counts у500 cells/ mL. According to the Centers for Disease Control and Prevention (CDC) expanded surveillance HIV case definitions [17] , almost half the HIV-positive patients were CDC class C3 before the index episode of CAP.
Forty-four HIV-positive patients (39% overall, 60% of those with CD4 cell counts known to be !200 cells/mL) reported taking P. carinii pneumonia (PCP) prophylaxis (28 used trimethoprim/sulfamethoxazole, 13 used dapsone, and 3 used inhaled pentamidine). Details of antiretroviral therapy were not recorded, but no patient received highly active antiretroviral therapy (HAART) during this era.
Demographics. The demographic features of the study patients are presented according to HIV status in table 1. These features largely reflect the demographics of the HMC medical service census and include much higher proportions of men, ethnic and racial minorities, homeless persons, uninsured persons, and HIV-positive persons than the county population as a whole (data not shown). Compared with the HIV-negative group, HIV-positive patients were significantly younger and much more likely to be male, to be white, to live in a private dwelling, to have health insurance, and to be admitted through an outpatient clinic rather than the emergency department.
Substance abuse and HIV risk factors. Habits or conditions that may increase the risk of pneumonia were common (table  1) . HIV-positive patients were significantly less likely to be alcoholic but more often used marijuana. They also reported higher rates of injection drug and cocaine use, although the differences were not statistically significant. Overall, only 16% of patients reported having none of these risks. Potential risk factors for contracting HIV infection reported by HIV-positive patients included high-risk sexual contact, injection drug use, and blood transfusion. Of these, only high-risk sexual contact was reported significantly more often by HIV-positive than by HIV-negative patients.
Underlying diseases and prior treatment. Underlying chronic diseases also were common among our patients (table 2) . Asthma and COPD were particularly prevalent, followed by chronic liver disease, malignancy, congestive heart failure, seizure disorder, diabetes mellitus, chronic renal failure, and others. One-third of the patients reported a prior episode of pneumonia. Bronchiectasis, chronic aspiration, dementia, neutropenia, sickle cell anemia, splenectomy, and stroke were reported rarely (р5%). Comparing the HIV-negative and HIV-positive groups, COPD, congestive heart failure, and diabetes mellitus were reported significantly more often by HIV-negative patients. In contrast, reflecting their unique predisposition to respiratory infections and despite their younger age, far more HIV-positive patients reported a prior episode of pneumonia. Only 27% of patients reported having none of these underlying diseases. Overall, 14% of patients had taken an antibiotic with antibacterial activity within 48 h before admission. The rate of prior antibiotic use by HIV-positive patients was significantly higher than that of HIVnegative patients, even when only antibiotic drugs with antibacterial activity were considered (table 2) . Diagnostic evaluation. The diagnostic evaluation (largely reflecting practice at our institution during the study period) differed significantly between the HIV-negative and HIV-positive groups. Satisfactory expectorated sputum samples were collected significantly more often from HIV-negative than from HIV-positive patients (72% vs. 63%;
), closely matching P p .04 their self-reported rates of sputum expectoration. In contrast, HIV-positive patients were more often subjected to invasive diagnostic procedures, such as sputum induction (47% vs. 7%;
) and fiberoptic bronchoscopy (22% vs. 5%; ). P ! .001 P ! .001 The rate of collection of blood for culture did not differ significantly between the 2 groups (81% of HIV-negative vs. 86% of HIV-positive patients). Special diagnostic tests performed only for study purposes were completed less often, but the rates of collection of these samples did not differ according to HIV status. Serum samples were collected from 54% of HIV-negative and 51% of HIV-positive patients, but paired specimens were obtained from only 24% and 30%, respectively. We obtained nasopharyngeal swabs for culture of respiratory viruses from most consenting patients in the first year of the study but ceased this practice because of the poor diagnostic yields.
The diagnostic yields of these tests varied considerably. The yields of relatively noninvasive tests, such as expectorated sputum examination (14%) and blood cultures (11%), were modest and did not differ significantly according to HIV status. Yields of serologic testing also were similar between the 2 groups (31%). Yields of sputum induction (22% of HIV-negative vs.
43% of HIV-positive patients;
) and fiberoptic bron-P p .02 choscopy (16% vs. 64%;
) were significantly higher in P p .002 HIV-positive patients than in HIV-negative patients. Overall, prior antibiotic treatment had no impact on the proportion of cases of unknown etiology (41% if antibiotics were taken vs. 44% if no antibiotics were taken;
) but was associated P p .7 with nonsignificant trends toward lower sputum and blood culture yields.
Microbial causes of CAP. We were able to make either a presumptive or definitive etiologic diagnosis for 293 patients (56%). Aspiration pneumonia was suspected on clinical grounds in 81 patients. Of these, 13 had an alternative specific etiology, so 68 patients (13% overall) were assigned an aspiration pneumonia diagnosis. This was the single most common diagnosis in our HIV-negative patients but was rarely diagnosed in HIVpositive patients. A specific microbial pathogen was identified for the remaining 225 patients (table 3) .
Among the HIV-negative patients, bacterial pathogens were found in 33% of cases. Typical pyogenic bacterial pathogens were recovered from 20% of patients, and infection with atypical bacterial organisms (defined as M. pneumoniae, C. pneumoniae, and Legionella species) was diagnosed in 18%. The single most common pathogen identified was Streptococcus pneumoniae, followed by Legionella species, M. pneumoniae, C. pneumoniae, Haemophilus influenzae, and Staphylococcus aureus. Other bacterial pathogens, including Moraxella catarrhalis and non-Haemophilus gram-negative bacilli, were rarely identified. M. tuberculosis was isolated from 5% of the HIV-negative patients. Coinfection with 11 CAP pathogen was identified in 8% of HIV-negative patients.
The etiologic spectrum in the HIV-positive patients was quite different. Overall, bacterial pathogens were somewhat less prevalent than among HIV-negative patients (25% vs. 33%;
). Typical bacterial pathogens were present in 19% of P p .1 cases, and atypical bacterial pathogens were found in 12%. The single most common pathogen identified was P. carinii, which accounted for nearly one-third of the cases. M. tuberculosis was the next most common isolate, followed by S. pneumoniae, M. pneumoniae, Mycobacterium avium, Legionella species, CMV, S. aureus, Pseudomonas aeruginosa, H. influenzae, C. pneumoniae, and others. Two cases of endemic fungal infection were identified, both causing disseminated disease in patients with advanced AIDS. Coinfection was identified in 17% of HIVpositive patients, and copathogens (usually P. carinii) were detected in all 6 cases that were due to M. avium and in 4 of the 5 cases that were due to CMV.
PCP was twice as common among HIV-positive patients with CD4 lymphocyte counts known to be !200 cells/mL than among those with higher counts (38% vs. 18%;
). Although P p .03 PCP was more common than bacterial pneumonia overall, bacterial pneumonia (28%) was more prevalent than PCP (18%) among patients with CD4 lymphocyte counts у200 cells/mL. M. avium was detected exclusively in those with low CD4 lym- phocyte counts. The prevalence of other etiologic agents did not differ significantly according to CD4 lymphocyte count. Overall, the likelihood of establishing a diagnosis was significantly greater for HIV-positive than for HIV-negative patients (65% vs. 54%;
). P. carinii, P. aeruginosa, M. av-P p .03 ium, and CMV were found exclusively in HIV-positive patients, and M. tuberculosis infection was significantly more common in HIV-positive patients, whereas aspiration pneumonia was significantly more common in the HIV-negative group.
CAP-associated bacteremia. Bacteremia due to CAP pathogens was detected in 46 (11%) of the 430 patients who had blood cultures done and was equally common regardless of HIV status. Among those patients who were eventually diagnosed with cultivable bacterial infections, there was a trend toward a higher prevalence of bacteremia in the HIV-positive group (11 [61%] of 18 vs. 35 [44%] of 80;
). S. pneumoniae was by far the P p .2 most common blood isolate, present in 28 cases. Surprisingly, however, only 3 of the 28 cases of pneumococcal bacteremia occurred in HIV-positive patients.
Other CAP pathogens were isolated from the blood far less frequently. S. aureus was the second most common blood isolate. Four of the 6 cases were in HIV-positive patients, and 2 were thought to have endovascular infections and a hematogenous origin of their lung infection. P. aeruginosa bacteremia was identified in 3 patients with advanced AIDS and other comorbidity, including neutropenia, prior antibiotic and corticosteroid therapy, and chemotherapy for Kaposi's sarcoma. None had indwelling central venous catheters or a history of injection drug use. Other cases of bacteremia were due to Klebsiella species (2 cases), group A streptococci (2 cases), and viridans streptococci, H. influenzae, and Escherichia coli (1 case each). Only P. aeruginosa bacteremia occurred significantly more commonly in HIV-positive than in HIV-negative patients.
Severe CAP. Most of our patients met у1 of the CAP severity criteria suggested by the American Thoracic Society guidelines [9] , and HIV-negative patients were less likely than HIV-positive patients to be categorized as severe by this measure (69% vs. 80% respectively;
). We defined cases of P p .01 severe CAP as those that required admission to an intensive care unit within the first 24 h of hospitalization. Far fewer patients (18% in each group) met this criterion, usually because of respiratory failure that required mechanical ventilation (13% each). Elderly patients (age у65 years [all but one HIV-negative]) were much more likely than younger patients to have severe CAP (29% vs. 16%; ), whereas homeless pa-P p .003 tients were much less likely to have severe CAP (9% vs. 21%; ). Prior antibiotic use was more common in the cases P p .001 of severe CAP than in those without severe CAP (22 vs. 12%; ). Nevertheless, bacteremia was detected somewhat P p .03 more often in patients with severe CAP (14 vs. 8%; ), P p .07 and the cause of pneumonia was determined more often in the patients with severe CAP than in less severe cases (68 vs. 53%;
). P p .01
The microbial causes of severe CAP are presented according to HIV status in table 4. Aspiration pneumonia remained the leading diagnosis among HIV-negative patients. S. pneumoniae was the most common specific isolate, followed by C. pneumoniae, Legionella species, H. influenzae, and others. Notably, gram-negative bacillary infections were uncommon, accounting for only 3% of cases. Among HIV-positive patients, P. carinii remained the most common pathogen. P. aeruginosa, CMV, and M. avium each occurred several times, and S. pneumoniae, M. pneumoniae, Legionella species, Klebsiella pneumoniae, respiratory syncytial virus, Coccidioides immitis, and aspiration pneumonia were found in single cases. M. tuberculosis was found in 4 cases of severe CAP, with 3 of the cases occurring in HIV-negative patients. Two of these cases were associated with coinfection by other CAP pathogens.
Influence of CAP severity on etiology. To learn whether the etiology of CAP in hospitalized patients differed according to their initial severity of illness, we analyzed the prevalence of common etiologic agents of CAP according to our definition of severe CAP. Among HIV-negative patients, typical bacterial infections (29% vs. 18%; ) and aspiration pneumonia P p .03 (28% vs. 13%;
) were significantly more common in P p .004 those with severe CAP. This was offset mostly by a significant decrease in the number of cases of unknown etiology (33% vs.
49%;
). The prevalence of atypical bacterial infections P p .02 (13% vs. 19%;
) and particularly Legionella infections P p .2 (6% vs. 8%;
) was not higher in the severe CAP subgroup. P p .6 Gram-negative bacillary infection was 14-fold more common, and M. pneumoniae infection was 3-fold less common in severely ill patients, but the numbers were small and the differences were not statistically significant.
Although the numbers were smaller among the HIV-positive patients, gram-negative bacillary infections (20% vs. none;
) and CMV infection (15% vs. 2%; ) were sig-P p .001 P p .04 nificantly more common in the severe CAP subgroup. The prevalence of other causes of CAP, including both typical and atypical bacteria and P. carinii, did not differ according to initial severity of illness. ). P p .04
Discussion
The major goals of our study were to define local CAP epidemiology and to compare the etiology of CAP in a consecutive series of HIV-negative and HIV-positive patients. Our results are important for several reasons. Our study population was uniquely young and had unusually high rates of homelessness, alcoholism, cigarette smoking, and injection drug use. These features distinguish our study population from those in most other large prospective CAP etiology studies [14, [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] , from 2 large multicenter CAP cohorts [5, 35] , and from numerous smaller or retrospective studies. Also, ours is the first comprehensive CAP etiology data from hospitalized patients in western North America. Finally, ours is only the second study to report a direct comparison of the etiology of CAP in substantial numbers of hospitalized HIV-negative and HIV-positive patients [15] . Thus, our data help to place in perspective the results from a small and heterogeneous group of prospective studies of CAP etiology in various HIV-positive cohorts [36] [37] [38] [39] [40] [41] [42] [43] and from a larger number of retrospective series of HIV-positive patients with CAP.
An important finding of our study was the high prevalence of aspiration pneumonia. Few large prospective CAP etiology studies have attempted to identify aspiration cases, finding rates of 3%-9% [14, 15, 24, 28] . Although it is difficult to identify cases of aspiration pneumonia with certainty, our criteria for assigning an aspiration pneumonia diagnosis were the same as those used in the Pittsburgh study [14] . The high rate of aspiration pneumonia that we report is most likely explained by the high prevalence of risk factors for aspiration among our patients (primarily alcoholism and injection drug use). Our finding that aspiration pneumonia was much more common in HIV-negative than in HIV-positive patients confirms the experience of Mundy et al. [15] in Baltimore. It is possible that clinicians were biased to underestimate the risk of aspiration of HIV-positive patients. However, the major risk factor for aspiration in our population was alcoholism, which was nearly twice as common in the HIV-negative group.
S. pneumoniae was the single most common microbial isolate in our study, as in virtually every prior CAP etiology report. However, the prevalence of pneumococcal cases identified in prior CAP studies has varied greatly, depending on the sensitivity of the diagnostic tests used, and most have found a higher prevalence [7] . It is likely that we have underestimated the overall rate of S. pneumoniae infection in our patients because of the relative insensitivity of standard sputum examination and blood cultures and our lack of testing for pneumococcal antigen or serologic responses; the rate of prior antibiotic use in our study was lower than in most. The even lower prevalence of S. pneumoniae infection in our HIV-positive group is at odds with the increased risk of pneumococcal infection and bacteremia attributed to HIV infection [44] . This observation is probably explained by the much higher rate of prior antibiotic use in our HIV-positive group, which either lessened their risk of developing pneumococcal infection or made it impossible for us to detect by means of standard cultures.
Among our HIV-positive patients, the opportunistic pathogen P. carinii was the single most common cause of CAP, particularly in those with CD4 lymphocyte counts known to be !200 cells/mL. Overall, the prevalence of PCP barely exceeded that of bacterial pneumonia (31% vs. 28%). These data contrast with the higher prevalence of bacterial pneumonia (47%) over PCP (27%) in the Baltimore study [15] , probably because of differences in PCP prophylaxis; the subjects in the Baltimore study were much more likely to use inhaled pentamidine (59% vs. 7% in our study), which would be less likely than systemic antibiotics to prevent bacterial pneumonia. The incidence of bacterial pneumonia exceeded that of PCP in the multicenter Pulmonary Complications of HIV Infection Study [38] , but their subjects had far less advanced HIV infection at enrollment than did the HIV-positive group in our study. By the 5th year of observation in that study, when HIV infection had progressed, PCP had become more common than bacterial pneumonia [45] .
Haemophilus influenzae pneumonia and other gram-negative bacillary infections were rare, despite the inclusion of elderly and institutionalized patients and those with COPD. The 3 cases of P. aeruginosa pneumonia occurred only among severely ill patients with advanced AIDS and other risk factors, such as neutropenia and corticosteroid therapy.
The prevalence of the atypical bacterial causes of CAP (M. pneumoniae, C. pneumoniae, and Legionella species) is the most variable of all causes in the published studies, apparently because of the use of differing serologic techniques and interpretative criteria [46] . In our study, atypical pathogens were implicated in 19% of cases overall. Given that we relied exclusively on serologic tests to diagnose these infections and that we collected serum samples from only half our patients, it is likely that this is a substantial underestimate. Although many of our cases due to Mycoplasma and Chlamydia were diagnosed by single high antibody titers, we were careful to use accepted interpretive criteria [46] . Our experience contrasts with the much lower rate of atypical infections (8%) observed by Mundy et al. [15] , who used more stringent serologic criteria.
In particular, legionnaires disease appears to be a common cause of CAP in our region. This finding is consistent with the ranking of Washington State among the highest reporters of legionnaires disease to the CDC passive surveillance program [47] and with the regular appearance of cases among local immunocompromised populations [48] . On the basis of the greatly increased relative risk for Legionella infection attributed to HIV infection in the CDC study [47] , we anticipated more cases in our HIV-positive group. The serologic tests that we used may have been compromised by impaired humoral responses in our HIV-positive patients. Alternatively, the CDC data may be biased by their reliance on passive surveillance and the likelihood that comprehensive diagnostic evaluation and invasive testing is more often directed at those patients with CAP known to have HIV infection [47] . Notably, the prevalence of legionnaires disease also did not differ between HIV-negative and HIV-positive subjects in the Baltimore study [15] .
The low rate of infections with respiratory viruses that we detected may be explained by the relative insensitivity of viral cultures, compared with serologic testing, in the setting of CAP [29] . However, the prevalence of viral infections may vary among different CAP populations. Mundy et al. [15] found a similarly low prevalence of infection with respiratory viruses in a CAP population similar to ours, despite the use of both viral culture and serologic testing.
We were surprised to find tuberculosis so prevalent among our patients who presented with CAP. Although it may be difficult to discern whether tuberculosis has caused or merely accompanied the acute respiratory illness recognized as CAP, all our patients with tuberculosis presented with an acute respiratory illness, and fewer than half had evidence of infection with another CAP pathogen. The especially high prevalence of tuberculosis in our study can probably be explained by our inclusion of HIV-positive patients, by the high rates of homelessness, alcohol abuse, and injection drug use in our study population, and by the fact that a large proportion of our patients with CAP (39%) had culture of sputum for mycobacteria. One of few CAP studies from a developed nation that has reported mycobacterial testing of every sputum sample obtained found a 10% prevalence of tuberculosis [49] .
The isolation of other opportunistic pathogens, such as endemic fungi, M. avium, or CMV, was limited to the HIV-positive group. The 2 fungal isolates were associated with disseminated disease and were unequivocal pathogens. The significance of the CMV and M. avium isolates was less clear. We chose to report CMV and M. avium isolated from BAL samples from HIV-positive patients as potential pathogens, considering increasing evidence that they can cause lung infection in this setting [50, 51] . However, in 10 of our 11 cases in which CMV or M. avium were isolated, there was evidence of another CAP pathogen (usually P. carinii). This suggests that CMV and M. avium may serve as markers for depressed immunity or that they may play synergistic roles but that they are not necessarily primary CAP pathogens.
An unexpected finding of our study was that Legionella infections were not more common among our patients with severe CAP. This prompted us to review the evidence supporting recommendations to selectively target severe patients with CAP for treatment with an antibiotic active against Legionella [9] [10] [11] [12] . Early reports of severe CAP consistently found Legionella species to be the second most common cause [8] . However, recent studies have found Legionella in !3% of cases [52] [53] [54] , and direct comparisons of the prevalence of Legionella infection among patients admitted to intensive care units versus regular wards have demonstrated no difference [28, 54] . The failure to treat legionnaires disease initially may be a more critical omission in patients already seriously ill at presentation, but patients who presented with severe CAP do not necessarily appear to be more likely to have legionnaires disease.
With regard to the selection of empirical antibiotic therapy for hospitalized patients with CAP, our data support the use of antibiotic regimens with optimal activity against S. pneumoniae and against the mixed flora typically involved in cases of suspected aspiration. This is especially true for patients with CAP who are admitted to an intensive care unit. On the other hand, the high prevalence of atypical pathogens in our study and the lack of association between disease severity and an atypical etiology suggest that it may be reasonable to include an antibiotic with activity against atypical pathogens in the empirical treatment of all patients hospitalized with CAP. This approach is supported by preliminary evidence that macrolide or fluoroquinolone therapy is associated with a decreased length of stay and improved outcomes [55] [56] [57] . Until this strategy can be further tested, clinicians must also consider the evidence that many patients with CAP with atypical infections appear to recover without specific therapy [33, 58] .
Because of key differences in the etiologic spectrum between HIV-negative and HIV-positive patients, it is imperative to consider the risk of underlying HIV infection in all patients with CAP. Opportunistic infections such as PCP must be considered in all HIV-positive patients, although they are much more likely in those with low CD4 lymphocyte counts. In terms of empirical treatment for the bacterial causes of CAP, antibiotic therapy similar to that used in HIV-negative patients should be adequate unless severe illness or specific risk factors for Pseudomonas infection are present.
Our study has several limitations. As in most other CAP etiology studies, diagnostic testing was incomplete, and clinician biases may have influenced both the selection of diagnostic tests and the assignment of certain diagnoses such as aspiration. Although our study was one of the largest CAP etiology studies conducted in North America, the numbers of certain subgroups were small, which limits the power to detect potentially important differences. Our single institution and unique study population limit the generalizability of our findings but may make our findings more relevant to the care of similar patients admitted to other urban public hospitals that serve indigent populations. Finally, one might question the relevance of our data from HIV-positive patients collected before the era of HAART. Although HAART can diminish the incidence of opportunistic lung infections, questions remain about its impact on the incidence of other causes of pneumonia, especially after the discontinuation of prophylaxis against PCP and mycobacteria. Also, many patients will fail to benefit from HAART, either because of lack of awareness of their HIV infection or because of problems with HAART, such as cost and availability issues, compliance and tolerability issues, or virologic failure. Thus, CAP will continue to be an important problem for HIVpositive patients, despite advances in antiretroviral therapy [59] .
In conclusion, we report the etiology of CAP in a uniquely young and indigent population with a high prevalence of substance abuse hospitalized at an urban public hospital in the Pacific Northwest region of North America. Aspiration pneumonia and tuberculosis were unusually common, but the prevalences of other causes of CAP were similar to those reported from elsewhere around the world. HIV-positive patients harbored a unique spectrum of opportunistic pathogens, but the prevalence of common bacterial causes of CAP was similar to that in the HIV-negative patients. Initial disease severity appears to be an imperfect predictor of specific microbial etiologies. To facilitate the selection of optimal initial antibiotic therapy, we will need either better clinical predictive tools or more rapid and accurate diagnostic tests for the microbial causes of CAP.
